Drug Repurposing for the Treatment of Acute Myeloid Leukemia
Acute myeloid leukemia (AML) is a heterogeneous disease characterized by the accumulation of immature myeloid progenitor cells in the bone marrow, compromising of normal blood cell production and ultimately resulting in bone marrow failure. With a 20% overall survival rate at 5 years and 50% in the...
Furkejuvvon:
| Váldodahkkit: | , |
|---|---|
| Materiálatiipa: | Artigo |
| Giella: | Inglês |
| Almmustuhtton: |
Frontiers Media S.A.
2017-11-01
|
| Ráidu: | Frontiers in Medicine |
| Fáttát: | |
| Liŋkkat: | http://journal.frontiersin.org/article/10.3389/fmed.2017.00211/full |
| Fáddágilkorat: |
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
|